Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WYETH vs TEVA PHARMA (Israel) - Comparison Results

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 WYETH   TEVA PHARMA
EQUITY SHARE DATA
    WYETH
Mar-14
TEVA PHARMA
Dec-13
WYETH/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs1,0653,459-   
Low Rs5533,005-   
Sales per share (Unadj.) Rs289.51,985.4-  
Earnings per share (Unadj.) Rs38.7124.0-  
Cash flow per share (Unadj.) Rs39.9284.5-  
Dividends per share (Unadj.) Rs145.00108.57-  
Avg Dividend yield %17.93.4 533.6%  
Book value per share (Unadj.) Rs118.52,205.4-  
Shares outstanding (eoy) m22.72848.00-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.81.6 171.7%   
Avg P/E ratio x20.926.1 80.2%  
P/CF ratio (eoy) x20.311.4 178.5%  
Price / Book Value ratio x6.81.5 465.7%  
Dividend payout %374.787.5 428.0%   
Avg Mkt Cap Rs m18,3812,741,007 0.7%   
No. of employees `000NA44.9 0.0%   
Total wages/salary Rs m3590-   
Avg. sales/employee Rs Th037,459.7-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th02,340.1-  
INCOME DATA
Net Sales Rs m6,5771,683,624 0.4%  
Other income Rs m3470-   
Total revenues Rs m6,9251,683,624 0.4%   
Gross profit Rs m1,023461,061 0.2%  
Depreciation Rs m27136,089 0.0%   
Interest Rs m433,069 0.0%   
Profit before tax Rs m1,339291,903 0.5%   
Minority Interest Rs m01,326 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-191,619 -0.0%   
Tax Rs m460-3,564 -12.9%   
Profit after tax Rs m879105,175 0.8%  
Gross profit margin %15.627.4 56.8%  
Effective tax rate %34.3-1.2 -2,811.9%   
Net profit margin %13.46.2 214.0%  
BALANCE SHEET DATA
Current assets Rs m3,9641,137,114 0.3%   
Current liabilities Rs m2,081991,659 0.2%   
Net working cap to sales %28.68.6 331.4%  
Current ratio x1.91.1 166.1%  
Inventory Days Days3591 38.7%  
Debtors Days Days27896 289.4%  
Net fixed assets Rs m878549,909 0.2%   
Share capital Rs m2274,144 5.5%   
"Free" reserves Rs m2,4660-   
Net worth Rs m2,6931,870,187 0.1%   
Long term debt Rs m25860,875 0.0%   
Total assets Rs m4,8423,847,621 0.1%  
Interest coverage x306.09.8 3,113.5%   
Debt to equity ratio x00.5 2.0%  
Sales to assets ratio x1.40.4 310.4%   
Return on assets %18.23.6 507.9%  
Return on equity %32.65.6 580.6%  
Return on capital %49.44.9 1,002.2%  
Exports to sales %0.10-   
Imports to sales %34.70-   
Net fx Rs m-2,2910-   
CASH FLOW
From Operations Rs m1,188268,283 0.4%  
From Investments Rs m287-95,063 -0.3%  
From Financial Activity Rs m-4,296-321,823 1.3%  
Net Cashflow Rs m-2,821-148,604 1.9%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 82.88 Rs / USD

Compare WYETH With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  

Compare WYETH With: TORRENT PHARMA  GENNEX LAB.  LACTOSE INDIA  SAMRAT PHARMA  ZIM LABORATORIES  



Today's Market

Sensex Today Trades Lower | Metal & PSB Stocks Shine | TCS, Apollo Tyre Drop 3% Sensex Today Trades Lower | Metal & PSB Stocks Shine | TCS, Apollo Tyre Drop 3%(10:30 am)

Asian shares slipped before a Bank of Japan policy decision where authorities are likely to bring an end to the world's last negative rates regime.